Young women, mothers holding babies and some men lined up in a dusty field on the outskirts of Zimbabwe’s capital, Harare.
An initial consignment of 19, 200 doses of Lanacapavir, a six-monthly HIV prevention injection drug, has arrived in Uganda, ...
At 48 weeks, 1% of participants in both groups had an HIV-1 RNA level of 50 copies per milliliter or higher, meeting the prespecified noninferiority margin of 4%. Rates of viral suppression below 50 ...
Dar es Salaam. Health practitioners in Tanzania are optimistic after the official registration of Lenacapavir, a long-acting ...
Advocacy groups from 30 countries are urging Merck to create a global access strategy for its once-a-month HIV prevention ...
Uganda has received its first consignment of Lenacapavir, a long-acting HIV prevention injection administered twice a year, ...
NBC chief science correspondent Robert Bazell explains the significance of the trial. Why is the study on Truvado being called a major advance? A report out from the U.N. today shows that even though ...
Lawmakers in Georgia, the state with the highest rate of new HIV infections in the country, are moving to allow pharmacists to prescribe and administer HIV prevention drugs.
Zimbabwe's health authorities on Thursday began administering the long-acting HIV prevention drug lenacapavir, making the ...